samsambuka

QLGN sollte den Boden erreicht haben

Long
samsambuka Updated   
NASDAQ:QLGN   Qualigen Therapeutics, Inc.
QLGN sollte den Boden erreicht haben.

Viele Meilensteine kommen in nächster Zeit:

2020
- FastPack: cFN Stroke Assay & SARS-CoV-2 IgG Assay Completed
- Receive cFN Stroke Assay CE Mark & SARS-CoV-2 IgG Assay EUA
- AS1411 Preclinical IND Studies for COVID-19
- ALAN Preclinical IND Studies

2021
- Phase 1: AS1411 for COVID-19
- Phase 1: ALAN
- RAS-F Preclinical IND Studies
- Phase 2: AS1411 for COVID-19

2022
- Phase 2: ALAN
- Phase 1: RAS-F
Order cancelled:
Zone klar durchbrochen
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.